S K Sohn - JoVE Visualize

Showing results (11-20 of 57) with videos related to

Pageof 6

Sort By:

Bone Marrow Transplantation|May 16, 2006

Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantationD H Kim, S K Sohn, D I Won, et al.

The Journal of Pharmacy and Pharmacology|June 27, 1998

Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in ratsK B Kim, M S Chang, Y K Chung, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 26, 1998

Intramedullary fat necrosis of multiple bones associated with pancreatitisB C Ahn, J Lee, K J Suh, et al.

Yonsei Medical Journal|May 19, 2000

Rupture of the rectosigmoid colon with evisceration of the small bowel through the anusJ Jeong, J S Park, C G Byun, et al.

Bone Marrow Transplantation|May 11, 2004

Transplantation outcome in allogeneic PBSCT patients according to a new chronic GVHD grading system, including extensive skin involvement, thrombocytopenia, and progressive-type onsetS K Sohn, D H Kim, J G Kim, et al.

Bone Marrow Transplantation|July 20, 2002

GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantationS K Sohn, J G Kim, K W Seo, et al.

Transplantation Proceedings|February 3, 2005

Hickman catheter site infections after allogeneic stem cell transplantation: single-center experienceD H Kim, N Y Bae, W J Sung, et al.

Bone Marrow Transplantation|August 19, 2007

Time to first flare-up episode of GVHD can stratify patients according to their prognosis during clinical course of progressive- or quiescent-type chronic GVHDD H Kim, S K Sohn, J H Baek, et al.

Archives of Pharmacal Research|January 6, 1999

Biochemical and pharmacological properties of a new proton pump inhibitor, 2-amino-4,5-dihydropyrido[1,2-a]thiazolo [5,4-g] benzimidazole (YJA20379-5)S K Sohn, M S Chang, Y K Chung, et al.

Canadian Journal of Physiology and Pharmacology|October 27, 1999

Biochemical and pharmacological characteristics of a newly synthesized H+-K+ ATPase inhibitor, YJA20379-1, 2-amino-4,5-dihydro-8-phenylimidazole[2,1-b]thiazolo[5,4-g]benzothiazol eS K Sohn, M S Chang, W S Choi, et al.

Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:

Pageof 6

Bone Marrow Transplantation|May 16, 2006

Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantationD H Kim, S K Sohn, D I Won, et al.

The Journal of Pharmacy and Pharmacology|June 27, 1998

Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in ratsK B Kim, M S Chang, Y K Chung, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 26, 1998

Intramedullary fat necrosis of multiple bones associated with pancreatitisB C Ahn, J Lee, K J Suh, et al.

Yonsei Medical Journal|May 19, 2000

Rupture of the rectosigmoid colon with evisceration of the small bowel through the anusJ Jeong, J S Park, C G Byun, et al.

Bone Marrow Transplantation|May 11, 2004

Transplantation outcome in allogeneic PBSCT patients according to a new chronic GVHD grading system, including extensive skin involvement, thrombocytopenia, and progressive-type onsetS K Sohn, D H Kim, J G Kim, et al.

Bone Marrow Transplantation|July 20, 2002

GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantationS K Sohn, J G Kim, K W Seo, et al.

Transplantation Proceedings|February 3, 2005

Hickman catheter site infections after allogeneic stem cell transplantation: single-center experienceD H Kim, N Y Bae, W J Sung, et al.

Bone Marrow Transplantation|August 19, 2007

Time to first flare-up episode of GVHD can stratify patients according to their prognosis during clinical course of progressive- or quiescent-type chronic GVHDD H Kim, S K Sohn, J H Baek, et al.

Archives of Pharmacal Research|January 6, 1999

Biochemical and pharmacological properties of a new proton pump inhibitor, 2-amino-4,5-dihydropyrido[1,2-a]thiazolo [5,4-g] benzimidazole (YJA20379-5)S K Sohn, M S Chang, Y K Chung, et al.

Canadian Journal of Physiology and Pharmacology|October 27, 1999

Biochemical and pharmacological characteristics of a newly synthesized H+-K+ ATPase inhibitor, YJA20379-1, 2-amino-4,5-dihydro-8-phenylimidazole[2,1-b]thiazolo[5,4-g]benzothiazol eS K Sohn, M S Chang, W S Choi, et al.

Pageof 6